323 related articles for article (PubMed ID: 26003526)
1. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
[TBL] [Abstract][Full Text] [Related]
2. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
[TBL] [Abstract][Full Text] [Related]
3. Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
ScientificWorldJournal; 2014; 2014():854391. PubMed ID: 25386619
[TBL] [Abstract][Full Text] [Related]
4. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
[TBL] [Abstract][Full Text] [Related]
5. Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.
Tripathy RK; Aggarwal G; Bajaj P; Kathuria D; Bharatam PV; Pande AH
Appl Biochem Biotechnol; 2017 Aug; 182(4):1642-1662. PubMed ID: 28161867
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Sci; 2013 Dec; 22(12):1799-807. PubMed ID: 24123308
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
[TBL] [Abstract][Full Text] [Related]
8. Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1.
Bajaj P; Aggarwal G; Tripathy RK; Pande AH
Biochimie; 2014 Oct; 105():202-10. PubMed ID: 25107406
[TBL] [Abstract][Full Text] [Related]
9. Engineering human PON1 in an E. coli expression system.
Suzuki SM; Stevens RC; Richter RJ; Cole TB; Park S; Otto TC; Cerasoli DM; Lenz DE; Furlong CE
Adv Exp Med Biol; 2010; 660():37-45. PubMed ID: 20221869
[TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
11. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization.
Aharoni A; Gaidukov L; Yagur S; Toker L; Silman I; Tawfik DS
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):482-7. PubMed ID: 14695884
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3).
Kumar S; Jain KK; Singh A; Panda AK; Kuhad RC
Protein Expr Purif; 2015 Jun; 110():43-51. PubMed ID: 25497420
[TBL] [Abstract][Full Text] [Related]
13. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
Upadhyay V; Singh A; Panda AK
Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
[TBL] [Abstract][Full Text] [Related]
14. On-column refolding purification of DT389-hIL13 recombinant protein expressed in Escherichia coli.
Sun W; Dai X; Zheng Y; Wang J; Hou L; Du J; Hu HG
Protein Expr Purif; 2011 Jan; 75(1):83-8. PubMed ID: 20851185
[TBL] [Abstract][Full Text] [Related]
15. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
[TBL] [Abstract][Full Text] [Related]
16. Refolding and purification of the human secreted group IID phospholipase A2 expressed as inclusion bodies in Escherichia coli.
Fonseca RG; Ferreira TL; Ward RJ
Protein Expr Purif; 2009 Oct; 67(2):82-7. PubMed ID: 19376232
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic chips with multi-junctions: an advanced tool in recovering proteins from inclusion bodies.
Yamaguchi H; Miyazaki M
Bioengineered; 2015; 6(1):1-4. PubMed ID: 25531187
[TBL] [Abstract][Full Text] [Related]
18. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization.
Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T
Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370
[TBL] [Abstract][Full Text] [Related]
19. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme.
Zhao G; Meier TI; Hoskins J; Jaskunas SR
Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829
[TBL] [Abstract][Full Text] [Related]
20. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.
Stevens RC; Suzuki SM; Cole TB; Park SS; Richter RJ; Furlong CE
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12780-4. PubMed ID: 18711144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]